drugset / Trial / NCT00236691

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

NCT00236691

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of topiramate as add-on therapy in patients with difficult to control partial onset seizures who are taking one or two standard antiepileptic drugs.

Timeline

Start
1988-07
Primary completion
Completion
1990-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 600 mg Oral
Subject Topiramate Small molecule 800 mg Oral
Subject Topiramate Small molecule 1000 mg Oral

Indications